⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24688765 | 0.83 | — | — | |
| SCHEMBL361130 | 0.81 | — | — | |
| SCHEMBL9644773 | 0.80 | — | — | |
| SCHEMBL8653772 | 0.79 | TSHR (0.46) | — | |
| SCHEMBL2991686 | 0.78 | ALDH1A1 (0.47) | — | |
| SCHEMBL11854882 | 0.76 | — | — | |
| SCHEMBL9076991 | 0.75 | ALDH1A1 (0.44) | — | |
| SCHEMBL11859365 | 0.73 | ALDH1A1 (0.41) | — | |
| SCHEMBL11908474 | 0.73 | ALDH1A1 (0.41) | — | |
| SCHEMBL11847337 | 0.72 | TSHR (0.50) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115458808-A | Method for producing lithium fluorosulfonate, nonaqueous electrolytic solution, and nonaqueous electrolyte secondary battery | 三菱化学株式会社 | 2022-12-09 | — | — | CN | disclosed |
| CN-113387375-A | Method for producing lithium fluorosulfonate, nonaqueous electrolyte solution, and nonaqueous electrolyte secondary battery | 三菱化学株式会社 | 2021-09-14 | — | — | CN | disclosed |
| CN-108502904-B | Method for producing lithium fluorosulfonate, nonaqueous electrolyte solution, and nonaqueous electrolyte secondary battery | 三菱化学株式会社 | 2021-06-08 | — | — | CN | disclosed |
| US-20210009542-A1 | PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE THEREOF | ABBVIE INC. | 2021-01-14 | — | — | US | disclosed |
| US-10889815-B2 | RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) | SIRNA THERAPEUTICS, INC. (US) | 2021-01-12 | — | — | US | disclosed |
| CN-111646489-A | Method for producing lithium fluorosulfonate, nonaqueous electrolyte solution, and nonaqueous electrolyte secondary battery | 三菱化学株式会社 | 2020-09-11 | — | — | CN | disclosed |
| CN-106882820-B | Method for producing lithium fluorosulfonate, nonaqueous electrolyte solution, and nonaqueous electrolyte secondary battery | 三菱化学株式会社 | 2020-05-29 | — | — | CN | disclosed |
| US-10662428-B2 | RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) | SIRNA THERAPEUTICS, INC. (US) | 2020-05-26 | — | — | US | disclosed |
| US-20190233821-A1 | RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA) | BANK OF AMERICA, N.A. | 2019-08-01 | — | — | US | disclosed |
| US-10351852-B2 | RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) | SIRNA THERAPEUTICS, INC. (US) | 2019-07-16 | — | — | US | disclosed |
| US-20170283816-A1 | RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA) | BANK OF AMERICA, N.A. | 2017-10-05 | — | — | US | disclosed |
| US-9771588-B2 | RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) | SIRNA THERAPEUTICS, INC. (US) | 2017-09-26 | — | — | US | disclosed |
| US-9738899-B2 | RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) | SIRNA THERAPEUTICS, INC. (US) | 2017-08-22 | — | — | US | disclosed |
| US-9657294-B2 | RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) | SIRNA THERAPEUTICS, INC. (US) | 2017-05-23 | — | — | US | disclosed |
| EP-3116936-A1 | HIGH PERMITTIVITY POLYMERS BASED ON FUNCTIONALIZED SILICONES | EMPA Eidgenössische Materialprüfungs- und Forschungsanstalt (CH) | 2017-01-18 | — | — | EP | disclosed |
| WO-2015135086-A1 | HIGH PERMITTIVITY POLYMERS BASED ON FUNCTIONALIZED SILICONES | EMPA EIDGENÖSSISCHE MATERIALPRÜFUNGS- UND FORSCHUNGSANSTALT (CH) | 2015-09-17 | — | — | WO | disclosed |
| US-5696282-A | CATALYTIC REACTION OF A HYDROGEN SULFIDE OR MERCAPTAN WITH UNSATURATED CARBONYL OR CYANO COMPOUND | PHILLIPS PETROLEUM COMPANY (US) | 1997-12-09 | — | — | US | disclosed |
| US-5079244-A | Cardiovascular disorders including angina pectoris, hypotensive agents | CASSELLA AKTIENGESELLSCHAFT (DE) | 1992-01-07 | — | — | US | disclosed |
| US-4617295-A | INSECTICIDES, MITICIDES | UNION CARBIDE CORPORATION (US) | 1986-10-14 | — | — | US | disclosed |
| US-4568671-A | INSECTICIDES, MITICIDES | UNION CARBIDE CORPORATION (US) | 1986-02-04 | — | — | US | disclosed |